CardioFocus (Marlborough, Massachusetts), a developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), said that its HeartLight technology is the focus of a multicenter European clinical study for the treatment of drug-refractory persistent AF. Read More
